Professor John Atack



Prosiectau fel Prif Ymchwiliwr
null null 1 o 2 null null



Prosiectau fel Cyd-Ymchwiliwr
null null 1 o 2 null null

LIMK1 inhibitors - A novel disease-modifying approach for the treatment of fragile X syndrome - Cyllidwr:Medical Research Council (01.05.2019 - 30.04.2021)
Transforming Cardiff Translation - Cyllidwr:Wellcome Trust (01.07.2019 - 01.01.2022)
MHS3: A disease modifying approach to Huntington's disease - Cyllidwr:LoQus23 Therapeutics Ltd (01.10.2019 - 31.03.2021)

Diweddarwyd y tro diwethaf ar 2020-31-05 am 04:09